In contrast to subdued growth in the pharmaceutical markets of the former 15-state European Union (EU), pharmaceutical markets in the 'new' EU accession markets are expanding vibrantly. While the former has been increasing at eight per cent annually, t
IVAX Corporation announced today a revised offer to acquire the shares of Kutnowskie Zaklady Farmaceutyczne Polfa SA ("Polfa Kutno"). IVAX intends to acquire, in exchange for IVAX stock, up to 100%, but not less than 75%
Computer Sciences Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Vaccinia Immune Globulin (VIGIV), an intravenous immune globulin, to treat rare adverse reac
Idebenone, a compound similar to coenzyme Q10, continues to show promise in treating the heart complications of Friedreich's ataxia (FA), notes correspondence published in the Feb. 10 issue of
A venom component fro
Decision Resources, Inc., forecasts that Amgen's novel biological agent for the treatment of osteoporosis, AMG-162, will become a blockbuster by 2013. Premium pricing of AMG-162 will propel
Pharmaceutical market research spending during Launch exceeds all market research spending from Pre-Clinical to Phase III, according to a new industry report by Cutting Edge Information. This
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart fa
Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.
This Sunday (1 August), the European Working Time Directive - which has covered most UK workers since 1998 - will be applied to doctors in training for the first time. The directive introduces a maximum 58 hour working week (falling to 48 in 2009), as well as new minimum rest requirements.
Mr Simon Eccles, chairman of the BMA's Junior Doctors Committee, says: "This is health and safety legislation - it's being introduced to protect patients as well as doctors, and hospitals need to take it seriously. Where the directive is flouted, the BMA will provide doctors with information, advice, and where appropriate, legal support."
Each time hospitals breach the directive for individual doctors, they will be liable to fines of up to ?5000 from the Health and Safety Executive. They could also be taken to employment tribunals by junior doctors.
Yet evidence suggests many hospitals are struggling to meet the August deadline. A survey conducted by the NHS Confederation last month showed that a sixth of trusts do not expect to be compliant with the directive on 1 August.
In addition to supporting individual doctors, the BMA is prepared to name and shame trusts who allow the new limits to reduce the quality of training. In many hospitals the impetus to cut hours has resulted in fresh approaches to working patterns that have driven up standards. However, the majority of hospitals have simply introduced shift systems, which require doctors to work for long stretches of up to 13 hours. Where such systems are used to staff hospitals at night, trainees are often denied exposure to work that increases their knowledge.
Simon Eccles says: "We shouldn't forget that junior doctors are in hospitals to learn as well as look after patients. Safe hours must not mean unsafe training."
http://www.bma.org.uk